Meeting

Salona Global

Leadership

Les Cross

Chief Executive Officer (CEO) of Salona Global Medical Device Corp.

​Former CEO & Chairman, DJO Global (NYSE:DJO)

Former CEO & Chairman, Alphatec Spine (NASDAQ:ATEC)

​Les Cross focused on acquisition and integration as a means of strategic growth during his tenure as CEO of DJO Global, resulting in significant returns and a lucrative private equity exit to Blackstone. His extensive US capital market and medical device company acquisition experience will be the driving energy behind the acquisition of companies in the pipeline.​

He led the IPO of DJO Global, raising US$150 million and the sale of DJO Global to Blackstone for US$1.6 billion.

Salona Advisor 1 (2).jpg
Luke Faulstick BOD Photo.jpg

Luke Faulstick

Chief Operating Officer (COO) of Salona Global Medical Device Corp., President of South Dakota Partners

​Luke is President and COO of Salona Global Medical Device Corp. and President and CEO of South Dakota Partners Inc. a wholly owned subsidiary of Salona Global, Salona Global's first acquisition. In his executive career, Luke has held leadership positions at Power Partners Inc.  (Co-Owner/CEO/President); DJO Global (EVP/COO); Tyco Healthcare (General Manager); Graphic Controls (General Manager); Mitsubishi Consumer Electronics (Plant Manager); and Eastman Kodak. He is recognized globally as an expert on lean manufacturing and work-culture. As an investor and co-owner of PPI and SDP, Luke led organic growth and continuing acquisitions to increase revenues from $15M to $135M and later sold the businesses to private and public equity investors. 
 
Luke earned a B.S. in Engineering from Michigan State University (MSU); and an M.S. in Engineering from Rochester Institute of Technology (RIT). He previously served on the boards for Alphatec Spine (Sym. ATEC) and Microdental, Board of Director Member and Chairman of the Board for the Association of Manufacturing Excellence (AME) and most recently was a Board of Director Member of Orthofix (Sym. OFIX) where he was chairman of the Nominating and Governance Committee and a member of the Finance and Audit Committee. Currently he is a member of the Rady Children's Hospital Foundation Board of Trustees. 

Rick Greenwald 

Co-Founder and President of Simbex

Rick Greenwald is the President of Simbex, a wholly owned subsidiary of Salona Global and Salona Global’s second acquisition. Rick was also Co-Founder of iWalk (now BionX, acquired by OttoBock). He is co-founder and Executive Director of the non-profit National Institute for Sports Science and Safety and is an Adjunct Professor at Thayer School of Engineering at Dartmouth College.  He has led two federally funded medical technology Commercialization Centers as Co-Director of the NIH funded Center for Translation of Rehabilitation Engineering Advances and Technology (TREAT), a national rehabilitation infrastructure resource, and Co-Director of the previously FDA funded New England Pediatric Device Consortium (NEPDC). Dr. Greenwald’s research interests include biomechanics, injury prevention, sports equipment, product development, and technology commercialization.

Rick has developed Simbex into a recognized leader in the development of biofeedback and data acquisition products for the medical and rehabilitation industries. Dr. Greenwald and Simbex have received numerous research and development awards, including ones from NIH, NSF, and the Department of Defense, for product development through the Small Business Innovation Research (SBIR) program.

He is a Fellow of the National Academy of Inventors (NAI) and the American Institute of Medical and Biological Engineering (AIMBE). Rick serves as a Trustee for the Visiting Nurse and Hospice of Vermont and New Hampshire and is on the Board of Trustees of the New Hampshire Academy of Science. 

Rick holds a Biomedical Engineering PhD degree from Duke University, a Master of Science in Engineering from Thayer School of Engineering and received his PhD from the University of Utah. 
 

Greenwald.png

Salona Global

Board of Director

Salona Advisor 2 (1).jpg
Salona Advisor 3.jpg
Salona Advisor 4 (2).jpg
Salona Advisor 1 (2).jpg
Salona Advisor 2 (1).jpg
Salona Advisor 4 (1).jpg
Salona Advisor 3.jpg

​Chairman of the Board

- CEO

Les Cross

​Former CEO & Chairman, DJO Global (NYSE:DJO)

Former CEO & Chairman, Alphatec Spine (NASDAQ:ATEC)

​Les Cross focused on acquisition and integration as a means of strategic growth during his tenure as CEO of DJO Global, resulting in significant returns and a lucrative private equity exit to Blackstone. His extensive US capital market and medical device company acquisition experience will be the driving energy behind the acquisition of companies in the pipeline.

He led the IPO of DJO Global, raising US$150 million and the sale of DJO Global to Blackstone for US$1.6 billion

Vice-Chair of the Board

Chair of the Audit Committee

Jane Kiernan

​Former CEO, Salter Labs

Former Chair of the Audit Committee and Director, American Medical Systems (NASDAQ:AMMD);

​Jane Kiernan is an expert in healthcare management, growth, and corporate oversight. Her experience in the sale of American Medical Systems have given her substantial buy and sell side experience and familiarity with the current opportunities in the medical healthcare space.

Non-Executive Director

Ken Kashkin, MD

​COO of Chromocell Corporation

Former CMO, Ferring Pharma (Valued at over US$1B)

Former Sen. Executive at Abbot Laboratories (NYSE:ABT) 

Former Vice President at Baxter (NYSE: BAX)

Former Professor, Yale University Medical School

​Dr. Ken Kashkin brings over 30 years of experience in medical devices, research and development, and corporate governance to the board. An expert physician, Dr. Kashkin serves as a technical medical expert on all transactions for the Company. Dr. Kashkin received his undergraduate and medical degrees from University of California, Los Angeles and completed his education at the Yale University School of Medicine.

Non-Executive Director

Kyle Wilks

Former Senior Manager at Baxter (NYSE: BAX)

Former Senior Manager at Shire (NASDAQ: SHPG)

Former Executive Director, Montgomery Pacific Group

Former U.S. Naval Officer

​Kyle Wilks graduated from the US Naval Academy at Annapolis. After his time as a Naval Officer, he worked at Montgomery Pacific Group, a mid market healthcare private equity group as an Executive Director managing portfolio companies. A former senior manager at Baxter in the rare immune deficiency therapies division, and Shire in the rare disease division, he was later a professor of Leadership at the US Naval Academy. He has substantial expertise in finance, leadership and management; medical device and biologics manufacturing and global healthcare market strategy.

Salona Global

​Advisors

Salona's board and management team brings decades of combined experience in medical device M&A and operational integration. Management's deep industry connections have created a deep and robust pipeline of potential acquisition targets.

The Company has retained Michael Dalsin (Former Chairman of PHM) and Roger Greene (Former Vice Chairman of PHM, Harvard Law School, JD) as industry advisors.

In addition to the board and advisor driven pipeline, the internal M&A team in the California corporate office systematically searches for potential acquisition targets globally. The internal acquisition team is structured around the key metrics and infrastructure that drove both DJO Global and PHM to success. Using a well-honed 12 point process, our internal M&A team has developed and continues to develop a deep pipeline of acquisition targets.